A Forthcoming Shift of Pharmaceutical Sales Compensation Plans?
OpenSymmetry
JULY 20, 2016
Sales in the pharmaceutical industry has been a rigid and consistent business. However, a recent article from the Harvard Business Review suggests the stagnant methods of pharmaceutical sales rep compensation may be the root cause of an even bigger public health issue. Share your thoughts in the comments below!
Let's personalize your content